{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:08:05Z","timestamp":1789949285824,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,8,5]],"date-time":"2010-08-05T00:00:00Z","timestamp":1280966400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s10549-010-0899-7","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T05:20:40Z","timestamp":1280899240000},"page":"805-814","source":"Crossref","is-referenced-by-count":64,"title":["Bone mineral density loss during adjuvant chemotherapy in pre-menopausal women with early breast cancer: is it dependent on oestrogen deficiency?"],"prefix":"10.1007","volume":"123","author":[{"given":"David A.","family":"Cameron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet E.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,5]]},"reference":[{"key":"899_CR1","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1200\/JCO.1997.15.4.1341","volume":"15","author":"T Saarto","year":"1997","unstructured":"Saarto T, Blomqvist C, Valimaki M, Makela P, Sarna S, Elomaa I (1997) Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients. J Clin Oncol 15:1341\u20131347","journal-title":"J Clin Oncol"},{"key":"899_CR2","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1016\/S0959-8049(01)00317-3","volume":"37","author":"L Vehmanen","year":"2001","unstructured":"Vehmanen L, Saarto T, Elomaa I, Makela P, Valimaki M, Blomqvist C (2001) Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment. Eur J Cancer 37:2373\u20132378","journal-title":"Eur J Cancer"},{"key":"899_CR3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1200\/JCO.1996.14.1.78","volume":"14","author":"TJ Powles","year":"1996","unstructured":"Powles TJ, Hickish T, Kanis J (1996) Effect of tamoxifen on bone mineral density measured by dual-energy X-ray absorptiometry in healthy premenopausal and postmenopausal women. J Clin Oncol 14:78\u201384","journal-title":"J Clin Oncol"},{"key":"899_CR4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1200\/JCO.2005.02.3515","volume":"24","author":"L Vehmanen","year":"2006","unstructured":"Vehmanen L, Elomaa I, Blomqvist C, Saarto T (2006) Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status. J Clin Oncol 24:675\u2013680","journal-title":"J Clin Oncol"},{"key":"899_CR5","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1200\/JCO.2005.03.3969","volume":"24","author":"JA Petrek","year":"2006","unstructured":"Petrek JA, Naughton MJ, Case LD et al (2006) Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol 24:1045\u20131051","journal-title":"J Clin Oncol"},{"key":"899_CR6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10549-004-2625-9","volume":"90","author":"CL Shapiro","year":"2005","unstructured":"Shapiro CL, Phillips G, van Poznak CH et al (2005) Baseline bone mineral density of the total lumbar spine may predict for chemotherapy-induced ovarian failure. Breast Cancer Res Treat 90:41\u201346","journal-title":"Breast Cancer Res Treat"},{"key":"899_CR7","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1093\/humrep\/del201","volume":"21","author":"RA Anderson","year":"2006","unstructured":"Anderson RA, Themmen AP, Al-Qahtani A, Groome NP, Cameron DA (2006) The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod 21:2583\u20132592","journal-title":"Hum Reprod"},{"key":"899_CR8","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00198-007-0382-4","volume":"18","author":"P Tothill","year":"2007","unstructured":"Tothill P, Hannan WJ (2007) Precision and accuracy of measuring changes in bone mineral density by dual-energy X-ray absorptiometry. Osteoporos Int 18:1515\u20131523","journal-title":"Osteoporos Int"},{"key":"899_CR9","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1200\/JCO.2008.19.1783","volume":"27","author":"SL Hines","year":"2009","unstructured":"Hines SL, Mincey BA, Sloan JA et al (2009) Phase III randomised, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer. J Clin Oncol 27:1047\u20131053","journal-title":"J Clin Oncol"},{"key":"899_CR10","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1200\/JCO.2001.19.14.3306","volume":"19","author":"CL Shapiro","year":"2001","unstructured":"Shapiro CL, Manola J, Leboff M (2001) Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer. [see comments]. J Clin Oncol 19:3306\u20133311","journal-title":"J Clin Oncol"},{"key":"899_CR11","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1200\/JCO.2008.16.4707","volume":"26","author":"DM Hershman","year":"2008","unstructured":"Hershman DM, McMahon DJ, Crew KD et al (2008) Zoledronic acid prevents bone loss in premenopausal women undergoing adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol 26:4739\u20134745","journal-title":"J Clin Oncol"},{"key":"899_CR12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1515\/CCLM.2002.025","volume":"40","author":"H Rosenbrock","year":"2002","unstructured":"Rosenbrock H, Seifert-Klauss V, Kaspar S et al (2002) Changes of biochemical bone markers during the menopausal transition. Clin Chem Lab Med 40:143\u2013151","journal-title":"Clin Chem Lab Med"},{"key":"899_CR13","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1016\/j.ejca.2009.09.026","volume":"45","author":"P Hadji","year":"2009","unstructured":"Hadji P, Ziller M, Maskow C et al (2009) The influence of chemotherapy on bone mineral density, quantitative ultrasonometry and bone turnover in pre-menopausal women with breast cancer. Eur J Cancer 45:3205\u20133212","journal-title":"Eur J Cancer"},{"key":"899_CR14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s007740200016","volume":"20","author":"P Peris","year":"2002","unstructured":"Peris P, Alvarez L, Monegal A et al (2002) Effect of surgical menopause and Paget\u2019s disease of bone on the isomerization of type I collagen carboxyterminal telopeptide: evolution after antiresorptive therapy. J Bone Miner Metab 20:116\u2013120","journal-title":"J Bone Miner Metab"},{"key":"899_CR15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S8756-3282(99)00175-1","volume":"25","author":"P Peris","year":"1999","unstructured":"Peris P, Alvarez L, Monegal A et al (1999) Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy. Bone 25:349\u2013353","journal-title":"Bone"},{"key":"899_CR16","unstructured":"Zekri JM, Brown JE, Gutcher S, Ellis S, Coleman R (2007) Effects of high dose chemotherapy and autologous peripheral stem cells transplantation on skeletal health. Clinical Oncology (Royal College of Radiologists) 16, S27, Abstract P2.01"},{"key":"899_CR17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2006.01.051","volume":"125","author":"L Sun","year":"2006","unstructured":"Sun L, Peng Y, Sharrow AC et al (2006) FSH directly regulates bone mass [see comment]. Cell 125:247\u2013260","journal-title":"Cell"},{"key":"899_CR18","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cell.2006.12.002","volume":"127","author":"MJ Seibel","year":"2006","unstructured":"Seibel MJ, Dunstan CR, Zhou H, Allan CM, Handelsman DJ (2006) Sex steroids, not FSH, influence bone mass. Cell 127:1079","journal-title":"Cell"},{"key":"899_CR19","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1002\/1097-0142(20011101)92:9<2419::AID-CNCR1591>3.0.CO;2-K","volume":"92","author":"A Banfi","year":"2001","unstructured":"Banfi A, Podesta M, Fazzuoli L et al (2001) High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors: a mechanism for post-bone marrow transplantation osteopenia. Cancer 92:2419\u20132428","journal-title":"Cancer"},{"key":"899_CR20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/01.blo.0000073348.50837.f2","volume":"4","author":"BL Leeuwen Van","year":"2003","unstructured":"Van Leeuwen BL, Verkerke GJ, Hartel RM et al (2003) Chemotherapy decreases epiphyseal strength and increases bone fracture risk. Clin Orthop Relat Res 4:243\u2013254","journal-title":"Clin Orthop Relat Res"},{"key":"899_CR21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1053\/ctrv.2000.0180","volume":"26","author":"BL Leeuwen Van","year":"2000","unstructured":"Van Leeuwen BL, Kamps WA, Jansen HW, Hoekstra HJ (2000) The effect of chemotherapy on the growing skeleton. Cancer Treat Rev 26:363\u2013376","journal-title":"Cancer Treat Rev"},{"key":"899_CR22","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1080\/02841860802001467","volume":"47","author":"NH Bjarnason","year":"2008","unstructured":"Bjarnason NH, Hitz M, Jorgensen NR (2008) Adverse bone effects during pharmacological breast cancer therapy. Acta Oncol 47:747\u2013754","journal-title":"Acta Oncol"},{"key":"899_CR23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/8756-3282(94)00032-U","volume":"16","author":"DL Wheeler","year":"1995","unstructured":"Wheeler DL, Vander Griend RA, Wronski TJ, Miller GJ, Keith EE, Graves JE (1995) The short- and long-term effects of methotrexate on the rat skeleton. Bone 16:215\u2013221","journal-title":"Bone"},{"key":"899_CR24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S8756-3282(98)00097-0","volume":"23","author":"J Gram","year":"1998","unstructured":"Gram J, Junker P, Nielsen HK, Bollerslev J (1998) Effects of short-term treatment with prednisolone and calcitriol on bone and mineral metabolism in normal men. Bone 23:297\u2013302","journal-title":"Bone"},{"key":"899_CR25","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/BF02556112","volume":"49","author":"P Geusens","year":"1991","unstructured":"Geusens P, Vanderschueren D, Verstraeten A et al (1991) Short-term course of 1, 25(OH)2D3 stimulates osteoblasts but not osteoclasts in osteoporosis and osteoarthritis. Calcif Tissue Int 49:168\u2013173","journal-title":"Calcif Tissue Int"},{"key":"899_CR26","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1210\/jcem-72-2-382","volume":"72","author":"MF Prummel","year":"1991","unstructured":"Prummel MF, Wiersinga WM, Lips P et al (1991) The course of biochemical parameters of bone turnover during treatment with corticosteroids. J Clin Endocrin Metab 72:382\u2013386","journal-title":"J Clin Endocrin Metab"},{"key":"899_CR27","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1210\/jc.2004-1444","volume":"90","author":"GE-J Fuleihan","year":"2005","unstructured":"Fuleihan GE-J, Salamoun M, Mourad YA et al (2005) Pamidronate in the prevention of chemotherapy-induced bone loss in premenopausal women with breast cancer: a randomized controlled trial. J Clin Endocrinol Metab 90:3209\u20133214","journal-title":"J Clin Endocrinol Metab"},{"key":"899_CR28","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1200\/JCO.2005.02.7102","volume":"25","author":"MF Gnant","year":"2007","unstructured":"Gnant MF, Mlineritsch B, Luschin-Ebengreuth G et al (2007) Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group. J Clin Oncol 25:820\u2013828","journal-title":"J Clin Oncol"},{"key":"899_CR29","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","volume":"356","author":"DM Black","year":"2007","unstructured":"Black DM, Delmas PD, Eastell R et al (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809\u20131822","journal-title":"N Engl J Med"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-0899-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-010-0899-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-0899-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:32:31Z","timestamp":1559233951000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-010-0899-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,5]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["899"],"URL":"https:\/\/doi.org\/10.1007\/s10549-010-0899-7","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,5]]}}}